↓ Skip to main content

Dove Medical Press

Long-term safety of aromatase inhibitors in the treatment of breast cancer

Overview of attention for article published in Therapeutics and Clinical Risk Management, February 2008
Altmetric Badge

Mentioned by

wikipedia
1 Wikipedia page

Citations

dimensions_citation
51 Dimensions

Readers on

mendeley
104 Mendeley
citeulike
1 CiteULike
Title
Long-term safety of aromatase inhibitors in the treatment of breast cancer
Published in
Therapeutics and Clinical Risk Management, February 2008
DOI 10.2147/tcrm.s1566
Pubmed ID
Authors

Jean-Marc A Nabholtz

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 104 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 104 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 26 25%
Student > Master 12 12%
Researcher 9 9%
Student > Ph. D. Student 9 9%
Student > Doctoral Student 8 8%
Other 13 13%
Unknown 27 26%
Readers by discipline Count As %
Medicine and Dentistry 24 23%
Pharmacology, Toxicology and Pharmaceutical Science 20 19%
Nursing and Health Professions 7 7%
Biochemistry, Genetics and Molecular Biology 5 5%
Psychology 5 5%
Other 12 12%
Unknown 31 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 July 2023.
All research outputs
#8,533,995
of 25,371,288 outputs
Outputs from Therapeutics and Clinical Risk Management
#461
of 1,323 outputs
Outputs of similar age
#46,811
of 172,943 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#16
of 21 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,323 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has gotten more attention than average, scoring higher than 55% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 172,943 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 17th percentile – i.e., 17% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 21 others from the same source and published within six weeks on either side of this one. This one is in the 9th percentile – i.e., 9% of its contemporaries scored the same or lower than it.